Your browser doesn't support javascript.
loading
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
Nemet, Ital; Kliker, Limor; Lustig, Yaniv; Zuckerman, Neta; Erster, Oran; Cohen, Carmit; Kreiss, Yitshak; Alroy-Preis, Sharon; Regev-Yochay, Gili; Mendelson, Ella; Mandelboim, Michal.
Afiliação
  • Nemet I; Ministry of Health, Ramat Gan, Israel.
  • Kliker L; Ministry of Health, Ramat Gan, Israel.
  • Lustig Y; Ministry of Health, Ramat Gan, Israel.
  • Zuckerman N; Ministry of Health, Ramat Gan, Israel.
  • Erster O; Ministry of Health, Ramat Gan, Israel.
  • Cohen C; Sheba Medical Center Tel Hashomer, Ramat Gan, Israel.
  • Kreiss Y; Sheba Medical Center Tel Hashomer, Ramat Gan, Israel.
  • Alroy-Preis S; Ministry of Health, Jerusalem, Israel.
  • Regev-Yochay G; Sheba Medical Center Tel Hashomer, Ramat Gan, Israel.
  • Mendelson E; Ministry of Health, Ramat Gan, Israel michal.mandelboim@sheba.health.gov.il.
  • Mandelboim M; Ministry of Health, Ramat Gan, Israel michal.mandelboim@sheba.health.gov.il.
N Engl J Med ; 386(5): 492-494, 2022 02 03.
Article em En | MEDLINE | ID: mdl-34965337
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Eficácia de Vacinas / Vacina BNT162 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Eficácia de Vacinas / Vacina BNT162 Idioma: En Ano de publicação: 2022 Tipo de documento: Article